Hims & Hers will offer branded semaglutide instead of compounded GLP-1 drugs
For example, administration of synthetic miR-132 has been reported to enhance neurogenesis in an AD mouse model, partly by reducing A burden and tau phosphorylation through repression of the inositol 1,4,5-trisphosphate 3-kinase B (ITPKB)-BACE1 pathway [103]
Glutathiones key role in the aging process has been put to the test by Danish researchers who examined the glutathione levels of centenarians
Improves Metabolic and Cardiovascular Biomarkers: Treatment results in lower blood pressure, improved insulin sensitivity, reduced triglycerides and non-HDL cholesterol, and favorable changes in adiponectin and leptin, all contributing to cardiovascular and metabolic benefits 1,4
The most important factors are purity verification, manufacturing origin, and documentation
At the higher doses, results were very consistent: All participants lost at least 5% of their body weight Around 3 in 4 lost 15% or more With placebo, only around 1 in 4 lost 5% or more Phase 3 update (TRIUMPH-4, 68 weeks, topline results) In December 2025 , Eli Lilly shared early (topline) results from a larger phase 3 study (TRIUMPH-4)